HARVARD BIOSCIENCE INC (HBIO) Stock News

NASDAQ:HBIO - Nasdaq - US4169061052 - Common Stock - Currency: USD

0.57 +0.01 (+2.55%)

Premarket: 0.57 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

HBIO Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: Benzinga - Mentions: SRPT MEIP WINT RCKT ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

8 days ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

8 days ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

2 months ago - By: Benzinga - Mentions: CLSD WINT NCNA GTBP ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

2 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Appoints John Duke to Board of Directors

2 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Appoints John Duke to Board of Directors

2 months ago - By: Yahoo Finance - Mentions: ENTG HUBS

Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark

2 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces First Quarter 2025 Financial Results

2 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces First Quarter 2025 Financial Results

3 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

3 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

4 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces CFO Transition

4 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces CFO Transition

4 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

4 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

5 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

5 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

5 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

5 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

5 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

5 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

6 months ago - By: Harvard Bioscience, Inc.

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference